Back to results
US 2020/0390760 A1Published application
Purine inhibitors of human phosphatidylinositol 3-kinase delta
AssigneeMerck Sharp & Dohme Corp.
InventorsMeredeth A. McGowan, Jason D. Katz, Hua Zhou, David James Witter, Chaomin Li, Kathryn A. Lipford, Joey L. Methot, Abdelghani A. Achab, Xavier Fradera, Shimin Xu, Jianmin Fu
Life of this patent
Estimating the term…
Abstract
The instant invention provides compounds of formula I which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases such as inflammation, asthma, COPD and cancer.
Claims21
A compound of Formula (I):
- or a pharmaceutically acceptable salt thereof, wherein
- A is selected from:
- wherein A is substituted with 0, 1, 2, or 3 R4, each R4 is independently selected from C1-C10 alkyl, C1-10 haloalkyl, C3-12 heterocycloalkylC0-6 alkyl, C3-12 cycloalkyl(C0-6 alkyl), amino, C3-12 cycloalkyl(C0-6 alkyl)aminocarbonyl, C1-6 alkylamino(C0-6 alkyl), C3-12 heterocycloalkylcarbonyl(C0-6 alkyl), C1-10 alkylcarbonyl(C0-6 alkyl), C3-12 cycloalkylcarbonyl(C0-6 alkyl), C1-10 alkylcarboxy, or C1-10 alkyloxy(C0-6 alkyl), wherein each R4 is independently substituted by 0, 1, 2, or 3 R5 independently selected from halogen, hydroxy, C1-6 alkyl, C1-4 alkoxy, or C1-6 haloalkyl;
- each R1 and R2 is independently selected from:
- hydrogen, or cyano provided that only one of R1 or R2 is cyano and the other is hydrogen;
- and
- R3 is hydrogen, C1-6 haloalkyl, or C1-6 alkyl.
4 more elements
Dependencies are inferred from the claim text.